Orlistat in South Africa: how it works and who it suits

What is orlistat and how does it work?

Orlistat is a capsule that blocks fat digestion. It binds to the lipase enzymes your stomach and pancreas release to break down dietary fat, so about 30% of the fat in a meal passes through undigested instead of being absorbed as calories. Appetite, hormones and the brain are left alone.

Because the medicine acts inside the gut, almost none of it enters the bloodstream: plasma levels after a dose are close to unmeasurable. That is why most of its side effects are local and digestive rather than systemic.

The dose is one 120 mg capsule with each main meal, taken during the meal or up to an hour after it. If you skip a meal, or the meal contains no fat, you skip the capsule. The effect shows up in stool fat within 24 to 48 hours of starting.

That mechanism is the opposite of the injectable class. GLP-1 medicines change how hungry and how full you feel, and leave digestion alone; orlistat changes digestion and leaves hunger alone. How GLP-1 treatment works in South Africa covers that side of the ledger.

Is orlistat available in South Africa?

Yes. Orlistat was registered in South Africa in June 1999 under the brand name Xenical, which makes it the longest-serving medicine on the local weight management list. Community pharmacies dispense it once a doctor has assessed you and authorised a treatment plan.

The South African obesity guideline published in the SAMJ in October 2025 lists four medicines registered for long-term weight management: orlistat (Xenical), liraglutide (Saxenda), naltrexone/bupropion (Contrave) and semaglutide (Wegovy). Tirzepatide, sold as Mounjaro, has since joined the injectable options on South African shelves.

Phentermine, widely known here as Duromine, is registered for short-term use only, under three months, and sits outside the long-term list. The differences are unpacked in Duromine vs GLP-1 medicines.

Within that list, orlistat holds two distinctions: it is one of only two oral options, and the only medicine of any kind that works in the gut instead of the brain or the hormone system.

What schedule is orlistat in South Africa?

Orlistat 120 mg is a Schedule 3 medicine in South Africa. A pharmacy may only dispense it after a doctor has assessed you and authorised treatment; it does not sit on the shelf next to the supplements, and no website may lawfully sell it to you directly.

The schedules carve out one exception. Doses up to 60 mg per main meal, capped at 180 mg per day, drop to Schedule 2, the tier a pharmacist can handle at the counter. That carve-out exists for lower-dose products like Alli, covered below. The strength registered and stocked in South Africa is the 120 mg capsule, so in practice the doctor route is the route.

Scheduling cuts both ways. It adds a consultation where a supplement asks for none, and in return you get a registered medicine with verified contents, a package insert that binds the manufacturer, and a nationally regulated price.

Xenical, generic orlistat and Alli: what is the difference?

All three contain the same molecule. Xenical is the originator brand of orlistat 120 mg, registered in South Africa since 1999. Generic orlistat means the same 120 mg capsule from another manufacturer. Alli is a 60 mg half-dose brand sold over the counter in the United States and United Kingdom.

Same molecule means same mechanism and same side effect profile; the halved dose in Alli simply blocks less fat. The Department of Health's Medicine Price Registry lists everything registered here under the name, which is the quickest way to check what a box actually contains.

Where the capsule fits among the wider tablet options, registered and otherwise, is mapped in weight loss pills in South Africa.

Can you buy Alli in South Africa?

Not from a local pharmacy shelf. Alli, the 60 mg orlistat brand GSK sells over the counter in the US and UK, is not a standard line in South African pharmacies, and searches for it here mostly land on international shipping sites. The orlistat dispensed locally is the 120 mg strength.

The Schedule 2 carve-out in the schedules makes a 60 mg pharmacist-counter product legally possible, but a medicine must also be registered and marketed here before a pharmacy can stock it, and the South African obesity guideline lists only the 120 mg capsule.

Ordering medicine through overseas websites sidesteps SAHPRA oversight entirely: nobody local has verified how the stock was stored, whether it is authentic, or whether the capsules contain what the label claims. That caution applies to a mild fat-blocker as much as to any injectable.

If what attracts you to Alli is a gentler dose with fewer digestive effects, that trade-off is worth raising with a doctor, who can weigh a lower-intensity plan against the registered options.

How much weight do you lose on orlistat?

A few kilograms more than diet alone, on average. Across randomised trials of orlistat 120 mg three times a day, people lost about 2.9% more of their body weight over a year than those on placebo, roughly an extra 3 kg for a 100 kg person. Individual results vary.

The categorical numbers from the same analysis: 54% of people on the capsule lost at least 5% of their body weight in a year, against 33% on placebo, and 26% lost at least 10%, against 14%. So the capsule roughly doubles the odds of a meaningful result without guaranteeing one.

The longest test was the XENDOS trial: 3,305 people with obesity followed for four years. Average loss was 5.8 kg with orlistat against 3.0 kg with placebo, and progression to type 2 diabetes fell by 37.3% in the orlistat group. Individual results vary.

The South African obesity guideline is blunt about the ceiling: modest weight loss above placebo, plus frequent digestive side effects, limit its use. The numbers are small next to the newer injectables, but they were earned over four years of follow-up and nearly three decades on the market.

How does orlistat compare with GLP-1 medicines?

GLP-1 medicines produce several times orlistat's weight loss in trials, at several times the published cost, through a different mechanism with different side effects. The South African obesity guideline's comparison puts orlistat at 2.9% more loss than placebo at one year, liraglutide at 5.4% and semaglutide at 12.5%.

Those figures come from separate trials with separate designs, not head-to-head contests, and individual results vary on every row. The side effect profiles barely overlap: orlistat's troubles are oily and digestive, while the GLP-1 class leans to nausea, constipation and vomiting.

Some people cannot take one class and tolerate the other well, and history with one medicine changes the calculus on the next. The right option is decided by a doctor on assessment.

What are the side effects of orlistat?

Mostly digestive, and directly tied to the fat you eat. In first-year trial data, 26.6% of users had oily spotting, 23.9% wind with an oily discharge, 22.1% faecal urgency and 20% fatty or oily stools. The more fat in a single meal, the stronger these effects.

They are the mechanism showing itself: fat that is not absorbed has to leave. Most people find the effects strongest in the early weeks and manageable once the plate adjusts, which is why the recommended diet keeps fat moderate and spreads it across the day.

The capsule can also reduce absorption of the fat-soluble vitamins A, D, E and K. A multivitamin containing them is commonly advised, taken at bedtime or at least two hours away from a dose.

Rare but serious problems are on record. Severe liver injury has been reported in rare cases, and in June 2026 the US FDA added kidney stone and acute kidney injury warnings to orlistat labels after reviewing twelve cases reported over 17 years. Severe stomach pain, yellowing skin or eyes, blood in the urine or flank pain: stop the capsules and seek medical care immediately.

It also interacts with warfarin, ciclosporin, levothyroxine and antiepileptic medicines, so the doctor needs your full medicine list at assessment.

Who should not take orlistat?

Orlistat is contraindicated in chronic malabsorption syndrome and cholestasis, and is not for use while pregnant, trying to conceive or breastfeeding. It must not be used by anyone with an eating disorder other than obesity, or by children under 12. A history of kidney stones now belongs in the conversation too.

People with type 2 diabetes can often use it, but under closer monitoring: losing weight lowers blood sugar, so glucose-lowering medicine doses may need adjusting, and trials found smaller weight loss in people with diabetes than without.

Screening for all of this is what the initial consultation is for, along with baseline measurements a follow-up can be judged against. What to expect sets out how a doctor-led assessment runs.

Who does orlistat actually suit?

Its South African registration covers adults with a BMI of 30 or more, or 27 and up with weight-related risk factors, alongside a reduced-energy diet. In practice it suits people who want a capsule rather than an injection, need the lowest-cost registered option, or cannot use GLP-1 medicines.

The routine is more demanding than it looks. Three capsules a day tied to meals, a consistently lower-fat plate, and side effects that flag every high-fat lapse. A Canadian persistence analysis found 18% of people still taking it at six months, 6% at one year and 2% at two years.

The registration builds in its own checkpoint: if you have not lost at least 5% of your body weight after 12 weeks, treatment is stopped. Nobody should drift along for a year on a capsule that is not working.

Weigh those realities with a doctor rather than against a price list. For some people the modest, cheap, non-injectable option is exactly right; for others it wastes three months better spent on treatment that fits.

What does orlistat cost in South Africa?

Far less than the GLP-1 injections, under the same price rules. Every registered medicine in South Africa carries one national Single Exit Price, and the SAMJ obesity guideline grades orlistat two on its four-step cost scale, against four for liraglutide and semaglutide.

What drives the monthly figure: three capsules a day means about 90 capsules a month, the registered packs hold 42 or 84, and pharmacies may only add a regulated dispensing fee on top of the fixed medicine price. Dischem, Clicks and independent pharmacies therefore price within touching distance of one another; generic brands, where stocked, usually come in lower.

Published rand figures for orlistat rarely appear in the press, so check the number yourself: the Department of Health's Medicine Price Registry at mpr.gov.za lists the current regulated price of every registered orlistat product, and a call to the dispensary confirms the till price and stock. We do not sell medicine. Prices vary by pharmacy and dose; confirm with your pharmacy.

What should you eat while taking orlistat?

A reduced-energy diet with roughly 30% of calories from fat, spread evenly across three main meals. That is the diet orlistat was tested alongside, and it doubles as self-defence: the more fat lands in one meal, the more likely the oily side effects become.

Skip the capsule when a meal is skipped or contains no fat; the medicine has nothing to act on. The registration itself recommends eating rich in fruit and vegetables, and spreading fat through the day rather than saving it for one large dinner.

Keep the roles straight: the diet creates the deficit, the capsule enlarges it by roughly a third of the fat you still eat. A takeaway-heavy week defeats both at once.

The kitchen principles overlap heavily with eating on the injectable medicines: protein first, fibre, regular meal structure. What to eat on GLP-1 medication covers them in detail, and nearly all of it serves an orlistat plan unchanged.

What happens when you stop taking orlistat?

Fat absorption returns to normal within about 48 to 72 hours of the last capsule; the medicine leaves no lasting change behind. From there, weight follows the pattern trials show across obesity treatment: without a deliberate maintenance plan, most people regain over time.

Orlistat does hold one maintenance credential. In people who had first lost weight on a very low energy diet, those taking orlistat regained 4.6 kg over three years against 7.0 kg on placebo. It slowed regain; it did not stop it. Individual results vary.

Obesity behaves like blood pressure: treated and managed rather than cured, whichever medicine is involved. Plan the maintenance phase with your doctor before stopping, not after the regain has started. The same ground is covered in keeping weight off after stopping GLP-1 medication, and the principles transfer directly.

Frequently asked questions